222 related articles for article (PubMed ID: 26519280)
1. Phenotypical Differences in Neuronal Cultures Derived via Reprogramming the Fibroblasts from Patients Carrying Mutations in Parkinsonian Genes LRRK2 and PARK2.
Konovalova EV; Novosadova EV; Grivennikov IA; Illarioshkin SN
Bull Exp Biol Med; 2015 Oct; 159(6):772-5. PubMed ID: 26519280
[TBL] [Abstract][Full Text] [Related]
2. Generation of an induced pluripotent stem cell line (CSC-44) from a Parkinson's disease patient carrying a compound heterozygous mutation (c.823C>T and EX6 del) in the PARK2 gene.
Marote A; Pomeshchik Y; Goldwurm S; Collin A; Lamas NJ; Pinto L; Salgado AJ; Roybon L
Stem Cell Res; 2018 Mar; 27():90-94. PubMed ID: 29353703
[TBL] [Abstract][Full Text] [Related]
3. Derivation, Characterization, and Neural Differentiation of Integration-Free Induced Pluripotent Stem Cell Lines from Parkinson's Disease Patients Carrying SNCA, LRRK2, PARK2, and GBA Mutations.
Momcilovic O; Sivapatham R; Oron TR; Meyer M; Mooney S; Rao MS; Zeng X
PLoS One; 2016; 11(5):e0154890. PubMed ID: 27191603
[TBL] [Abstract][Full Text] [Related]
4. LRRK2 Expression Is Deregulated in Fibroblasts and Neurons from Parkinson Patients with Mutations in PINK1.
Azkona G; López de Maturana R; Del Rio P; Sousa A; Vazquez N; Zubiarrain A; Jimenez-Blasco D; Bolaños JP; Morales B; Auburger G; Arbelo JM; Sánchez-Pernaute R
Mol Neurobiol; 2018 Jan; 55(1):506-516. PubMed ID: 27975167
[TBL] [Abstract][Full Text] [Related]
5. G2019S LRRK2 mutant fibroblasts from Parkinson's disease patients show increased sensitivity to neurotoxin 1-methyl-4-phenylpyridinium dependent of autophagy.
Yakhine-Diop SM; Bravo-San Pedro JM; Gómez-Sánchez R; Pizarro-Estrella E; Rodríguez-Arribas M; Climent V; Aiastui A; López de Munain A; Fuentes JM; González-Polo RA
Toxicology; 2014 Oct; 324():1-9. PubMed ID: 25017139
[TBL] [Abstract][Full Text] [Related]
6. Neurite Aggregation and Calcium Dysfunction in iPSC-Derived Sensory Neurons with Parkinson's Disease-Related LRRK2 G2019S Mutation.
Schwab AJ; Ebert AD
Stem Cell Reports; 2015 Dec; 5(6):1039-1052. PubMed ID: 26651604
[TBL] [Abstract][Full Text] [Related]
7. Mutations in LRRK2 impair NF-κB pathway in iPSC-derived neurons.
López de Maturana R; Lang V; Zubiarrain A; Sousa A; Vázquez N; Gorostidi A; Águila J; López de Munain A; Rodríguez M; Sánchez-Pernaute R
J Neuroinflammation; 2016 Nov; 13(1):295. PubMed ID: 27863501
[TBL] [Abstract][Full Text] [Related]
8. Generation of an induced pluripotent stem cell line (CSC-41) from a Parkinson's disease patient carrying a p.G2019S mutation in the LRRK2 gene.
Marote A; Pomeshchik Y; Collin A; Goldwurm S; Lamas NJ; Pinto L; Salgado AJ; Roybon L
Stem Cell Res; 2018 Apr; 28():44-47. PubMed ID: 29414418
[TBL] [Abstract][Full Text] [Related]
9. Cytogenetic Analysis of the Results of Genome Editing on the Cell Model of Parkinson's Disease.
Vetchinova AS; Simonova VV; Novosadova EV; Manuilova ES; Nenasheva VV; Tarantul VZ; Grivennikov IA; Khaspekov LG; Illarioshkin SN
Bull Exp Biol Med; 2018 Jul; 165(3):378-381. PubMed ID: 30006877
[TBL] [Abstract][Full Text] [Related]
10. LRRK2 mutations cause mitochondrial DNA damage in iPSC-derived neural cells from Parkinson's disease patients: reversal by gene correction.
Sanders LH; Laganière J; Cooper O; Mak SK; Vu BJ; Huang YA; Paschon DE; Vangipuram M; Sundararajan R; Urnov FD; Langston JW; Gregory PD; Zhang HS; Greenamyre JT; Isacson O; Schüle B
Neurobiol Dis; 2014 Feb; 62():381-6. PubMed ID: 24148854
[TBL] [Abstract][Full Text] [Related]
11. Analysis of Leucine-rich repeat kinase 2 (LRRK2) and Parkinson protein 2 (parkin, PARK2) genes mutations in Slovak Parkinson disease patients.
Bognar C; Baldovic M; Benetin J; Kadasi L; Zatkova A
Gen Physiol Biophys; 2013 Mar; 32(1):55-66. PubMed ID: 23531835
[TBL] [Abstract][Full Text] [Related]
12. A common leucine-rich repeat kinase 2 gene mutation in familial and sporadic Parkinson's disease in Russia.
Illarioshkin SN; Shadrina MI; Slominsky PA; Bespalova EV; Zagorovskaya TB; Bagyeva GKh; Markova ED; Limborska SA; Ivanova-Smolenskaya IA
Eur J Neurol; 2007 Apr; 14(4):413-7. PubMed ID: 17388990
[TBL] [Abstract][Full Text] [Related]
13. Generation of induced pluripotent stem cells (IBMSi011-A) from a patient with Parkinson's disease carrying LRRK2 p.I1371V mutation.
Lin HI; Cheng YC; Ko HW; Wen CH; Lu HE; Huang CY; Hsieh PCH; Lin CH
Stem Cell Res; 2019 May; 37():101447. PubMed ID: 31029016
[TBL] [Abstract][Full Text] [Related]
14. Adenoviral-mediated expression of G2019S LRRK2 induces striatal pathology in a kinase-dependent manner in a rat model of Parkinson's disease.
Tsika E; Nguyen AP; Dusonchet J; Colin P; Schneider BL; Moore DJ
Neurobiol Dis; 2015 May; 77():49-61. PubMed ID: 25731749
[TBL] [Abstract][Full Text] [Related]
15. Decreased Sirtuin Deacetylase Activity in LRRK2 G2019S iPSC-Derived Dopaminergic Neurons.
Schwab AJ; Sison SL; Meade MR; Broniowska KA; Corbett JA; Ebert AD
Stem Cell Reports; 2017 Dec; 9(6):1839-1852. PubMed ID: 29129681
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and clinical features of LRRK2 mutations in patients with Parkinson's disease in southern Spain.
Gao L; Gómez-Garre P; Díaz-Corrales FJ; Carrillo F; Carballo M; Palomino A; Díaz-Martín J; Mejías R; Vime PJ; López-Barneo J; Mir P
Eur J Neurol; 2009 Aug; 16(8):957-60. PubMed ID: 19473361
[TBL] [Abstract][Full Text] [Related]
17. Generation and characterization of induced pluripotent stem cells from a Parkinson's disease patient carrying the digenic LRRK2 p.G2019S and GBA1 p.N409S mutations.
Oleksy C; Massart F; Goldwurm S; Arado A; Arena G; Boussaad I; Krüger R
Stem Cell Res; 2023 Oct; 72():103212. PubMed ID: 37832355
[TBL] [Abstract][Full Text] [Related]
18. Generation of gene-corrected iPSC line, KIOMi002-A, from Parkinson's disease patient iPSC with LRRK2 G2019S mutation using BAC-based homologous recombination.
Lee SY; Chung SK
Stem Cell Res; 2019 Dec; 41():101649. PubMed ID: 31731184
[TBL] [Abstract][Full Text] [Related]
19. Modeling neurological diseases with induced pluripotent cells reprogrammed from immortalized lymphoblastoid cell lines.
Fujimori K; Tezuka T; Ishiura H; Mitsui J; Doi K; Yoshimura J; Tada H; Matsumoto T; Isoda M; Hashimoto R; Hattori N; Takahashi T; Morishita S; Tsuji S; Akamatsu W; Okano H
Mol Brain; 2016 Oct; 9(1):88. PubMed ID: 27716287
[TBL] [Abstract][Full Text] [Related]
20. Deciphering the role of heterozygous mutations in genes associated with parkinsonism.
Klein C; Lohmann-Hedrich K; Rogaeva E; Schlossmacher MG; Lang AE
Lancet Neurol; 2007 Jul; 6(7):652-62. PubMed ID: 17582365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]